Indian benchmark indices Sensex and Nifty50 traded in the red on Friday after the U.S. imposed steep tariffs on multiple ...

Investing.com - Shares of European drugmakers fell on Friday after President Donald Trump issued letters to more than a dozen ...

The U.S. will raise tariffs on scores of nations, effective at 12:01 a.m. on Aug. 7, according to an executive order Trump signed on Thursday. When the action is taken, the result will be ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Shares in Novo Nordisk fell as much as 6% on Friday to their lowest since August 2021, extending recent losses to wipe out ...

Shares in Wegovy maker Novo Nordisk fell around 4% on Friday to their lowest since August 2021, after U.S. President Donald ...

Brokerage Investec downgraded Sun Pharma shares by two notches to 'sell' while Choice Equity Broking gave an 'Add' rating ...

A global stock selloff extended to a sixth day - the longest losing streak since September 2023 - after President Donald Trump boosted tariffs for imports from across the world.

Only two out of the 20 constituents on the Nifty Pharma index are trading with gains. Sun Pharma is the top loser on the ...

But within weeks, Novo Nordisk’s partnership crumbled amid a messy war of words. Novo Nordisk accused Hims & Hers of continuing to deceptively sell large volumes of copycat vers ...

Fintel reports that on July 31, 2025, HSBC downgraded their outlook for Novo Nordisk A (NYSE:NVO) from Buy to Hold. Analyst ...

Pomerantz LLP is investigating claims on behalf of investors of  Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO).  Such investors are advised to contact Danielle Peyton ...